Assignee
MEMORY PHARM CORP
US·34 granted patents·18 pending applications·304 citations·filing 2000–2013
Top patents by PatentIndex Score
52 records- 0197US7902217B2Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereofMEMORY PHARM CORP·Filed 2008·Granted Mar 8, 2011·86 cites·14 claims
- 0292US7696229B2Compounds having 5-HT6 receptor affinityMEMORY PHARM CORP·Filed 2007·Granted Apr 13, 2010·22 cites·30 claims
- 0387US7655802B2Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogsMEMORY PHARM CORP·Filed 2006·Granted Feb 2, 2010·9 cites·35 claims
- 0487US6699890B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2002·Granted Mar 2, 2004·21 cites·75 claims
- 0586US7396833B2Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereofMEMORY PHARM CORP·Filed 2004·Granted Jul 8, 2008·20 cites·44 claims
- 0686US7226930B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2004·Granted Jun 5, 2007·27 cites·37 claims
- 0785US7087625B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2003·Granted Aug 8, 2006·24 cites·84 claims
- 0884US7358057B2QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cellsMEMORY PHARM CORP·Filed 2003·Granted Apr 15, 2008·14 cites·35 claims
- 0982US7625924B2Nicotinic alpha-7 receptor ligands and preparation and uses thereofMEMORY PHARM CORP·Filed 2005·Granted Dec 1, 2009·5 cites·34 claims
- 1082US7429664B2Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereofMEMORY PHARM CORP·Filed 2003·Granted Sep 30, 2008·11 cites·42 claims
- 1181US7700631B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2006·Granted Apr 20, 2010·5 cites·19 claims
- 1279US7153871B2Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogsMEMORY PHARM CORP·Filed 2003·Granted Dec 26, 2006·9 cites·40 claims
- 1377US7244745B2Heterocyclic compounds, methods for the preparation thereof, and uses thereofMEMORY PHARM CORP·Filed 2003·Granted Jul 17, 2007·8 cites·69 claims
- 1476US8691841B2Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereofMEMORY PHARM CORP·Filed 2013·Granted Apr 8, 2014·2 cites·28 claims
- 1576US7943773B2Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereofMEMORY PHARM CORP·Filed 2009·Granted May 17, 2011·1 cites·14 claims
- 1676US7632831B21H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereofMEMORY PHARM CORP·Filed 2005·Granted Dec 15, 2009·2 cites·43 claims
- 1775US7723348B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2008·Granted May 25, 2010·2 cites·61 claims
- 1875US7585882B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2005·Granted Sep 8, 2009·2 cites·35 claims
- 1975US7495017B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2007·Granted Feb 24, 2009·2 cites·45 claims
- 2074US7235579B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2002·Granted Jun 26, 2007·8 cites·48 claims
- 2172US7576080B2Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitorsMEMORY PHARM CORP·Filed 2005·Granted Aug 18, 2009·2 cites·43 claims
- 2271US7432266B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2005·Granted Oct 7, 2008·1 cites·57 claims
- 2370US7405230B2Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogsMEMORY PHARM CORP·Filed 2003·Granted Jul 29, 2008·5 cites·39 claims
- 2468US7332486B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2003·Granted Feb 19, 2008·3 cites·33 claims
- 2566US6656717B1Cyclic AMP phosphodiesterase isoforms and methods of useMEMORY PHARM CORP·Filed 2000·Granted Dec 2, 2003·10 cites·10 claims
- 2664US7790722B2Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereofMEMORY PHARM CORP·Filed 2008·Granted Sep 7, 2010·0 cites·19 claims
- 2761US7696198B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2004·Granted Apr 13, 2010·1 cites·17 claims
- 2859US7700630B2Heterocyclic compounds, methods for the preparation thereof, and uses thereofMEMORY PHARM CORP·Filed 2007·Granted Apr 20, 2010·0 cites·33 claims
- 2959US2009069361A1Methods of treatment using (+)- isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, 4-dihydro-2, 6-dimethyl-pyridine-3, 5-dicarboxylateMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 3058US7205320B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2004·Granted Apr 17, 2007·2 cites·71 claims
- 3156US2010010017A1Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitorsMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 3254US7335654B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2003·Granted Feb 26, 2008·0 cites·62 claims
- 3353US7964600B2Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereofMEMORY PHARM CORP·Filed 2010·Granted Jun 21, 2011·0 cites·33 claims
- 3453US2010056491A14'-amino cyclic compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 3552US2010029689A1Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 3652US2010022581A1Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 3752US2010056531A1Alkyl-substituted 3' compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 3851US7342021B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2002·Granted Mar 11, 2008·0 cites·68 claims
- 3951US2010029629A1Acyclic compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 4051US2010016297A1Alkyl-substituted 3' compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 4151US2006166316A1Phosphodiesterase 10a7 isoforms and methods of useMEMORY PHARM CORP·Filed 2004·Application pending·0 cites
- 4250US2009069337A13' substituted compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 4350US2010298306A1(1,4-Diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone Ligands for Nicotinic Acetylcholine Receptors, Useful for the Treatment of DiseaseMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 4449US7994199B2Heterocyclic compounds, methods for the preparation thereof, and uses thereofMEMORY PHARM CORP·Filed 2010·Granted Aug 9, 2011·0 cites·14 claims
- 4549US2008318941A14' substituted compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 4649US2008200471A16' substituted compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 4747US2003149052A1Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2003·Application pending·0 cites
- 4846US2006168668A1Phosphodiesterase 2a and methods of useMEMORY PHARM CORP·Filed 2004·Application pending·0 cites
- 4945US7932248B21H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereofMEMORY PHARM CORP·Filed 2006·Granted Apr 26, 2011·0 cites·23 claims
- 5045US2006142188A1Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereofMEMORY PHARM CORP·Filed 2004·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MEMORY PHARM CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →